EP2510942
Notkun natríumúretísks peptíðs við meðferð á hjartabilun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.4.2006EP published:
2.9.2015EP application number:
12156696.2
EP translation filed:
24.11.2015Grant published:
15.12.2015EPO information:
European Patent Register
Max expiry date:
6.4.2026Expiry date:
6.4.2018
Title:
Use of natriuretic peptide for treating heart failure
Timeline
Today
7.4.2006EP application
2.9.2015EP Publication
24.11.2015Translation submitted
15.12.2015Registration published
6.4.2018Expires
Owner
Name:
Cardiorentis AGAddress:
Steinhauser Str. 74, 6300, Zug, CH
Inventor
Name:
Mitrovic, VeselinAddress:
Bad Nauheim, DE
Name:
Lüss, HartmutAddress:
Hannover, DE
Name:
Forssmann, Wolf-GeorgAddress:
Kleines Wiesental, DE
Name:
Meyer, MarkusAddress:
Hannover, DE
Name:
Döhler, Klaus-DieterAddress:
Hannover, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
669751 PDate:
8.4.2005Country:
US
Number:
669786 PDate:
7.4.2005Country:
US
Number:
732585 PDate:
1.11.2005Country:
US
Classification
Categories:
A61K 38/22, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 19.4.2016
Expires: 6.4.2017
Payer: Guðjón Styrkársson, hrl.
Number: 12
Paid: 22.5.2017
Expires: 6.4.2018
Payer: Guðjón Styrkársson, hrl.